Alzheimers Vaccine

Texas Children's Vaccine Book Helps Spanish-Speaking Parents Understand Consequences of Vaccine-Preventable Diseases
The National Hispanic Medical Association applauds "Vaccine-Preventable Disease: The Forgotten Story" for powerful message HOUSTON, Aug. 31 /PRNewswire-USNewswire/ -- Texas Children's Hospital has adapted its medically acclaimed book, "Vaccine-Preventable Disease: The Forgotten Story" into a Spanish-language version featuring real-life stories about the impact of five diseases that are vaccine-preventable, yet prevalent in the Hispanic and Latino communities.

FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
SWIFTWATER, Pa., Aug. 26 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135. Menactra vaccine was the first quadrivalent conjugate vaccine licensed in the United States to help protect against meningococcal disease, a rare but serious disease that can take the life of a child within 24 hou...


Alzheimers Vaccine


Home Site Map This site may be for sale: Make Inquiry



Privacy Policy | Copyright/Trademark Notification